BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23509753)

  • 1. Mitochondria and cancer: past, present, and future.
    Verschoor ML; Ungard R; Harbottle A; Jakupciak JP; Parr RL; Singh G
    Biomed Res Int; 2013; 2013():612369. PubMed ID: 23509753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
    Sabharwal SS; Schumacker PT
    Nat Rev Cancer; 2014 Nov; 14(11):709-21. PubMed ID: 25342630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA and carcinogenesis (review).
    Grzybowska-Szatkowska L; Slaska B
    Mol Med Rep; 2012 Nov; 6(5):923-30. PubMed ID: 22895648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, prostate cancer, and biopsy sampling error.
    Parr RL; Mills J; Harbottle A; Creed JM; Crewdson G; Reguly B; Guimont FS
    Discov Med; 2013 Apr; 15(83):213-20. PubMed ID: 23636138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-related mitochondrial components and mitochondrial genome as targets of anticancer therapy.
    Giannattasio S; Guaragnella N; Arbini AA; Moro L
    Chem Biol Drug Des; 2013 Jan; 81(1):102-12. PubMed ID: 23253132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Mitochondrial-Nuclear Exchange (MNX) Mice to Identify Mitochondrial Determinants of Cancer Metastasis.
    Welch DR; Larson MA; Vivian CJ; Vivian JL
    Methods Mol Biol; 2023; 2660():43-59. PubMed ID: 37191789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
    Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
    PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial contributions to cancer cell physiology: potential for drug development.
    Preston TJ; Abadi A; Wilson L; Singh G
    Adv Drug Deliv Rev; 2001 Jul; 49(1-2):45-61. PubMed ID: 11377802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of mitochondrial genetics in cancer metastasis.
    Welch DR; Foster C; Rigoutsos I
    Trends Cancer; 2022 Dec; 8(12):1002-1018. PubMed ID: 35915015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
    Park JS; Sharma LK; Li H; Xiang R; Holstein D; Wu J; Lechleiter J; Naylor SL; Deng JJ; Lu J; Bai Y
    Hum Mol Genet; 2009 May; 18(9):1578-89. PubMed ID: 19208652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells.
    Delsite R; Kachhap S; Anbazhagan R; Gabrielson E; Singh KK
    Mol Cancer; 2002 Nov; 1():6. PubMed ID: 12495447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The First Mitochondrial Genomics and Evolution SMBE-Satellite Meeting: A New Scientific Symbiosis.
    Ostersetzer-Biran O; Lane N; Pomiankowski A; Burton R; Arnqvist G; Filipovska A; Huchon D; Mishmar D
    Genome Biol Evol; 2017 Nov; 9(11):3054-3058. PubMed ID: 29106528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA polymorphism and risk of cancer.
    Singh KK; Kulawiec M
    Methods Mol Biol; 2009; 471():291-303. PubMed ID: 19109786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
    Dickerson T; Jauregui CE; Teng Y
    Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue.
    Chattopadhyay E; De Sarkar N; Singh R; Ray A; Roy R; Paul RR; Pal M; Ghose S; Ghosh S; Kabiraj D; Banerjee R; Roy B
    Tumour Biol; 2016 Sep; 37(9):11861-11871. PubMed ID: 27055661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial plasticity in cell fate regulation.
    Bahat A; Gross A
    J Biol Chem; 2019 Sep; 294(38):13852-13863. PubMed ID: 31383739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
    Bellot GL; Liu D; Pervaiz S
    Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The maintenance of mitochondrial DNA integrity--critical analysis and update.
    Alexeyev M; Shokolenko I; Wilson G; LeDoux S
    Cold Spring Harb Perspect Biol; 2013 May; 5(5):a012641. PubMed ID: 23637283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.